LMOD2 p.Ala23Ser
c.67G>T · VCV3290992
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5526 | ambiguous |
|---|---|---|
| REVEL | 0.302 | indeterminate |
| SaProt | LLR -8.40 | tolerated |
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.93 | unconstrained · MANE · 7,778 bp · p 0.09 · regional, not allelic |
| Overall | ||
| CADD | 26.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00222% | 45,034 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,370 |
| European (non-Finnish) | 8.49e-05% | 1,178,387 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LMOD2
- Protein
- p.Ala23Ser
- Coding
- c.67G>T
- MANE Select
- NM_207163
- Type
- single nucleotide variant
- Location
- chr7:123656030 (GRCh38)
- Gene constraint
- LOEUF 0.984 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 67.14 · 6 PDB
- Residue 23
- the 'interaction with actin 1' region; the 'interaction with tropomyosin alpha' region; a turn
Similar variants
- LMOD2 p.Ala23Val Uncertain significance ★ ⚠ same residue
- LMOD2 p.Ala23Thr Uncertain significance ★ ⚠ same residue
- LMOD2 p.Arg231Cys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Glu276Lys Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Thr244Met Uncertain significance ★★ ⚠ same condition
- LMOD2 p.Ala287Pro Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala287Thr Uncertain significance ★ ⚠ same condition
- LMOD2 p.Ala528Val Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lmod2-p-ala23ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown